N-of-One Announces Agreement with Foundation Medicine to Provide the First Patient-Specific Genomic Diagnostic Solution for Precision Oncology  
5/31/2012 10:23:20 AM

WALTHAM, Mass.--(BUSINESS WIRE)--N-of-One, Inc., provider of Diagnostic Strategy Roadmaps™ and Treatment Strategy Roadmaps™ for personalized cancer care, announced today that the company has entered into a strategic collaboration with Foundation Medicine, Inc. to support the development of its fully informative molecular cancer profiles that can be used to guide individualized patient treatment strategies.